Skip to content
OpenCapital
Get started

Veracyte VCYT Testing revenue — Total Revenue

Similar metrics at other companies

Natera, Inc. logo
NTRATotal Revenue
$696.64M+38.8%
Idexx Laboratories logo
IDXXTotal Revenue
$1.14B+14.3%
Natera, Inc. logo
NTRAProduct revenues — Total revenues
$693.87M+38.8%
Labcorp Holdings logo
LHTotal Revenue
$3.54B+5.8%
Tempus AI, Inc. logo
TEMDiagnostics — Revenue
$261.1M+34.7%
Teradyne, Inc. logo
TERProduct Test — Revenue
$80.44M+8.4%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.28B+10.7%
Enterprise value$4.05B+7.4%
P/E48.6×-68.3×
P/S7.9×-0.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's testing revenue — total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's testing revenue — total revenue?
Veracyte (VCYT) reported testing revenue — total revenue of $135.09M in Q1 2026.
How has Veracyte's testing revenue — total revenue changed year-over-year?
Veracyte's testing revenue — total revenue increased by 25.9% year-over-year, from $107.31M to $135.09M.
What is the long-term trend for Veracyte's testing revenue — total revenue?
Over 4 years (2021 to 2025), Veracyte's testing revenue — total revenue has grown at a 27.2% compound annual growth rate (CAGR), from $188.18M to $493.15M.
What does testing revenue — total revenue mean?
This represents the total gross revenue generated from the company's diagnostic testing services and associated clinical products. It serves as a primary indicator of market adoption and the scale of the company's core diagnostic business operations.